The coronavirus nucleocapsid (N) protein is a major structural component of virions that associates with the genomic RNA to form a helical nucleocapsid. N appears to be a multifunctional protein since data also suggest that the protein may be involved in viral RNA replication and translation. All of these functions presumably involve interactions between N and viral RNAs. As a step toward understanding how N interacts with viral RNAs, we mapped high-efficiency N-binding sites within BCV-and MHV-defective genomes. Both in vivo and in vitro assays were used to study binding of BCV and MHV N proteins to viral and nonviral RNAs. N-viral RNA complexes were detected in bovine coronavirus (BCV)-infected cells and in cells transiently expressing the N protein. Filter binding was used to map N-binding sites within Drep, a BCV-defective genome that is replicated and packaged in the presence of helper virus. One high-efficiency N-binding site was identified between nucleotides 1441 and 1875 at the 3Ј end of the N ORF within Drep. For comparative purposes N-binding sites were also mapped for the mouse hepatitis coronavirus (MHV)-defective interfering (DI) RNA MIDI-C. Binding efficiencies similar to those for Drep were measured for RNA transcripts of a region encompassing the MHV packaging signal (nts 3949-4524), as well as a region at the 3Ј end of the MHV N ORF (nts 4837-5197) within MIDI-C. Binding to the full-length MIDI-C transcript (ϳ5500 nts) and to an ϳ1-kb transcript from the gene 1a region (nts 935-1986) of MIDI-C that excluded the packaging signal were both significantly higher than that measured for the smaller transcripts. This is the first identification of N-binding sequences for BCV. It is also the first report to demonstrate that N interacts in vitro with sequences other than the packaging signal and leader within the MHV genome. The data clearly demonstrate that N binds coronavirus RNAs more efficiently than nonviral RNAs. The results have implications with regard to the multifunctional role of N.
INTRODUCTION
The coronavirus genome is a single-stranded, positive-sense, 27-to 32-kb RNA molecule, the largest among all RNA viruses. The genomic RNA is encapsidated by multiple copies of the nucleocapsid (N) protein and is packaged as a helical nucleocapsid in the mature enveloped virion (Kennedy and Johnson-Lussenburg, 1975; Macneughton and Davies, 1978; Caul et al., 1979; Davies et al., 1981) . Recently it was suggested that coronaviruses contain a more structured, possibly icosahedral, core consisting of the membrane (M) and N proteins surrounding a helical nucleocapsid (Risco et al., 1996) .
All coronavirus N proteins are 50-to 60-kDa phosphoproteins, with an overall high basic amino acid content. Within any antigenic subgroup the amino acid sequence homology is high, whereas the proteins are highly divergent across the different antigenic subgroups (Lapps et al., 1987) . Three structural domains are present in the N protein (Parker and Masters, 1990) . The middle domain is responsible for RNA binding (Masters, 1992; Nelson and Stohlman, 1993; Nelson et al., 2000) . During a normal infection, N is one of the most abundantly expressed viral proteins, expressed at a much higher level than any of the viral replication factors that are expected to interact with viral RNAs.
Other functions, in addition to its known structural role, have been postulated for N. Data suggest that N may be involved in viral transcription (Compton et al., 1987; Baric et al., 1988) and translation control (Tahara et al., 1994) . MHV N colocalizes with putative replicase proteins in virus-infected cells, providing further support that N may be involved in RNA replication Denison et al., 1999) . It was recently demonstrated that N interacts with heterogeneous nuclear ribonucleoprotein A1 (hnRNP-A1), both in vitro and in vivo (Wang and Zhang, 1999) . Cellular hnRNP-A1 binds to MHV negativestrand leader and intergenic sequences (Li et al., 1997) . It has been postulated that hnRNP plays a role in MHV transcription (Zhang and Lai, 1995) .
In this study we analyzed N-RNA interactions to begin addressing the mechanism by which N recognizes viral RNAs. Multiple assays were used to gain insight into N-RNA interactions that may be involved in coronavirus RNA packaging, nucleocapsid assembly, and other postulated functions of N. Quantitative analysis of N-RNA interactions revealed that N interacts more efficiently with coronavirus RNA than with noncoronavirus RNA. High-efficiency binding regions were mapped for the BCV-defective genome RNA Drep and defective interfering (DI) MHV RNA MIDI-C (de Groot et al., 1992; Chang et al., 1994) (Fig. 1 ). Both defective genomes are replicated and packaged by their parental virus. BCV and MHV belong to the same antigenic subgroup. Sequence comparisons indicate that the two viruses are closely related (Lapps et al., 1987; Abraham et al., 1990a,b; Kienzle et al., 1990) . Even though the two viruses share many similarities, they appear to differ with regard to RNA packaging. BCV packages subgenomic RNA in addition to genomic RNA (Hofmann et al., 1990) , whereas MHV packages very little, if any, of its subgenomics. BCV Drep is replicated and packaged by BCV, but it does not contain any gene 1b sequence ( Fig. 1) (Chang et al., 1994; Cologna and Hogue, 2000) . MIDI-C contains part of gene 1b where a packaging signal maps (van der Most et al., 1991; Fosmire et al., 1992) (Fig. 1) . We recently identified a packaging signal in the BCV genome that is homologous to the MHV packaging signal (Cologna and Hogue, 2000) . Our analyses of N-binding sites within the BCV and MHV defective genomes provide the most comprehensive and comparative study to date of coronavirus N-RNA interactions.
RESULTS

BCV N-RNA complexes are present in virus-infected cells
When we began our investigation to understand how coronavirus RNAs are recognized by the N protein, our main focus was directed at the identification of a packaging signal for the bovine coronavirus-defective RNA Drep (Chang et al., 1994) . We hypothesized at the time, based on data from other studies in our lab, that Drep might contain a packaging signal within its N open reading frame (ORF).
Identification of a packaging signal within Drep by deletion mapping was not possible because of technical limitations. Drep replication is readily compromised by only small deletions or point mutations (Chang and Brian, 1996; Cologna and Hogue, unpublished data) . Therefore, toward our goal to identify a packaging signal for Drep, we initially assayed for N-viral RNA interactions using four different approaches. The rationale was that identification of N-binding sites on the Drep RNA could give us insight toward what interactions are important for Drep packaging.
We first determined which viral RNAs interact with N during a BCV infection. Mock-and BCV-infected HCT cells were metabolically labeled with [ 32 P]orthophosphate in the absence of actinomycin D. Both viral and cellular RNAs are labeled in the absence of the inhibitor, whereas only viral RNAs are labeled in the presence of the inhibitor. Cytoplasmic RNAs were either examined directly or after immunoprecipitation with antibodies specific for the N protein. Antibodies against the spike protein (S) or preimmune sera were used as controls. As expected, in the absence of actinomycin D a large amount of label was incorporated into ribosomal RNAs ( Fig. 2A, lanes 1 and 2) . Weaker viral RNA signals were observed over the background when total RNA from infected cells was analyzed directly ( Fig. 2A, lane 2) . Genomic and subgenomic RNAs were clearly visible from BCV-infected cells labeled in the presence of actinomycin D, whereas no RNAs were seen with mock-infected cells ( Fig. 2A, lanes 3 and 4) . A profile typical of virus genomic and subgenomic RNAs was observed for RNAs coimmunoprecipitated with antibodies against N ( Fig. 2A , lanes 5 and 6). Immunoprecipitation with the BCV S-specific antibodies demonstrated that the N-RNA complexes were specific for the N protein and that we were not merely recovering translation complexes. In all experiments, specific immunoprecipitation of the N and S proteins was verified by SDS-PAGE/Western blotting analysis (data not shown).
The coprecipitated RNAs from cells labeled in the absence of actinomycin D comigrated with viral RNAs that were labeled and analyzed directly from cells labeled in the presence of actinomycin D ( Fig. 2A , (Chang et al., 1994) and pMIDI-C is a cloned MHV-A59 DI (van der Most et al., 1991) . The various parts of the genome that are included in each defective genome are labeled. Drep includes a 30-nt reporter sequence (T) derived from the TGEV N gene (Chang et al., 1994) . The approximate position of the packaging signal (P) within the BCV and MHV genomes, as well as MIDI-C, is indicated. (B) Chimeric RNAs were made from coronavirus sequences (Drep, BCVN3Ј, and BCVpkg) cloned at the 5Ј end of a cassette that contains the CAT gene, the hepatitis delta virus ribozyme (r), and the T7 terminator (T7t).
compare lanes 4 and 6). No RNAs were recovered using control sera ( Fig. 2A , lanes 7-10). Therefore, the coimmunoprecipitated RNAs were assumed to be viral RNAs. To support this assumption, unlabeled N-RNA complexes were isolated and Northern blots were probed with a BCV N ORF-specific probe that recognizes genomic and all subgenomic RNAs. Genomic and subgenomic RNAs were readily detected in the total RNA fractions (Fig. 2B, lane 12) and in the N-RNA complexes isolated by immunoprecipitation from the same lysate (Fig. 2B, lane 14) , but not from mockinfected cell lysates (Fig. 2B, lanes 11 and 13) . No RNAs were coimmunoprecipitated with preimmune serum (Fig. 2B, lane 15) .
These results demonstrated for the first time that N interacts with all viral RNAs during a BCV infection. Since N-RNA complexes were isolated from cells labeled in the absence of actinomycin D, the results suggest that the N-viral RNA interactions are specific. Although we cannot rule out the possibility that weakly labeled cellular RNAs comigrated with the viral RNAs, no prominently labeled cellular RNAs appeared to be associated with N.
BCV N binds coronavirus RNA more efficiently than noncoronavirus RNA An in-solution binding assay (Geigenmuller-Gnirke et al., 1993) was used as a second approach to analyze N-RNA interactions and further address the question of specificity. In this assay in vitro generated, unlabeled N and Drep RNA transcripts were incubated with in vitro translated [ 35 S]methionine-labeled BCV N protein. Protein-RNA interactions were measured by comigration of [ 35 S]-labeled N protein with unlabeled RNA. When no RNA was included in the reaction mix, N protein did not enter the agarose gel (Fig. 3, lane 1) . A twofold molar excess of total cytoplasmic BHK RNA was included as a competitor in reactions (Fig. 3, lanes 2-7) . N protein interacted weakly with both 18S and 28S ribosomal RNAs when only BHK RNA was included in reactions (Fig. 3, lane 2) . However, when coronavirus-specific transcripts Drep and N were included, N protein appeared to preferentially bind the coronavirus RNAs over the ribosomal RNA (Fig. 3 , compare lanes 2-4).
Influenza virus neuraminidase (NA) gene transcripts were also examined to further assess what appeared to be preferential binding to coronavirus RNA. The fulllength transcript is comparable in size and nucleotide content to the BCV N gene. N protein did bind NA transcript (Fig. 3, lane 7) . Since the signal was distorted by comigration of full-length NA RNA with 18S ribosomal RNA, shorter NA transcripts were examined to more clearly assess N-binding to the NA RNA ( Fig. 3 , lanes 5 and 6). Binding to the NA RNA was less than half of that measured for a comparable molar amount of N RNA (Fig.  3 , lanes 3-6). The results provided further direct data that N interacts with coronavirus RNAs and suggested that the protein binds viral RNAs more efficiently than noncoronavirus RNAs.
To determine whether BCV N protein interacts with the N gene when expressed in the absence of a coronavirus infection, a third approach was used. BCV N and influenza virus NA genes were expressed using vTF7-3, the vaccinia virus recombinant that expresses T7 RNA polymerase (Fuerst et al., 1986) . Following infection with vTF7-3, BHK cells were transfected with plasmids that contained the BCV N gene or the influenza virus NA gene, singly and together ( N-specific transcripts were present in cells transfected with the N gene plasmid (Fig. 4A, lanes 1 and 3) , but not in vTF7-3-infected cells transfected with only the NA gene plasmid (Fig. 4A , lane 2). N-RNA complexes were coimmunoprecipitated from cells transfected with the N plasmid alone (Fig. 4A, lane 4) and from cells cotransfected with both N and NA plasmids (Fig. 4A , lane 6, 8ϫ exposure). No N transcripts were coprecipitated when only the NA gene was expressed (Fig. 4A , lane 5). The amount of N transcripts from cells transfected with only the N gene was always higher than when the N and NA plasmids were coexpressed. Transfection optimization experiments did not correct the disparity, which may explain in part the reason for the significant decrease in the amount of N-N RNA complexes that were recovered in the presence of NA RNA expression.
Using the NA gene-specific riboprobe NA transcripts were detected when the NA plasmid was transfected alone or in combination with N plasmid, but not when the latter was transfected alone (Fig. 4B, lanes 1-3) . No N-NA RNA complexes were immunoprecipitated with antibodies against the NA protein ( Fig. 4B , lanes 7-9), again indicating that our buffer conditions disrupted translation complexes. However, a very small amount of NA-RNA complex was detected when the coexpressed N and NA genes were immunoprecipitated with the N antibodies (Fig. 4B , lane 6, 8ϫ exposure).
The results were consistent with those from the insolution experiments. Absolute specificity of N-viral RNA interactions was not observed. However, N interacted more efficiently with its own ORF.
To determine whether the N protein interacts in trans with Drep RNA, we coexpressed both using the vaccinia T7 expression system as described above. Drep RNA expressed alone was immunoprecipitated with antibodies against N (data not shown). Drep contains an ORF consisting of a fusion between the amino-terminal portion of gene 1a and the entire N ORF (Chang et al., 1994) . The N portion of the Pol-N fusion protein apparently retains its RNA-binding function since Drep RNA-containing complexes were immunoprecipitated with N antibodies. The Pol-N fusion ORF is translated in vitro and immunoprecipitated with N-specific antibodies (Chang and Brian, 1996) ; therefore, expression of the Pol-N fusion protein made it impossible to definitively demonstrate interactions between N and Drep with this assay.
Mapping N-binding sites by filter binding
After establishing that N appeared to interact better with its viral RNAs than with noncoronavirus RNAs, we developed a nitrocellulose filter-binding assay to map and characterize the interactions of N with viral-specific RNA in a quantitative manner. This assay also allowed FIG. 4 . Isolation of N-RNA complexes from cells transiently expressing BCV N. vTF7-3-infected BHK cells were transfected with plasmids containing a cDNA copy of the N gene (pN.R1.1), the influenza NA gene (pNA.R1), or cotransfected with both plasmids. RNAs were divided in half and run on parallel denaturing agarose gels for Northern blotting using equal amounts of either a BCV N gene-specific riboprobe (A) or an influenza NA gene-specific riboprobe (B). Total cytoplasmic RNA from transfected cells was analyzed directly (lanes 1-3) or after immunoprecipitation with anti-N (lanes 4-6) or anti-NA (lanes 7-9) polyclonal sera. Right panels (lanes 4-9) were exposed eight times longer than the left panels. us to look more closely at specificity. The reaction conditions were initially established using purified histidine (his)-tagged BCV N protein that had been expressed in bacteria. We previously reported our preliminary results using the his-tagged N, which demonstrated that N binds Drep, MHV DI MIDI-C, and a transcript that contained the MHV packaging signal more efficiently than a noncoronavirus RNA (Cologna and Hogue, 1998) .
To directly demonstrate that the his-tagged N protein was binding to the Drep, MIDI-C, and MHV packaging signal RNAs, UV crosslinking was performed following incubation of filter-binding reactions. After RNase A digestion covalently crosslinked proteins were analyzed by SDS-PAGE. A protein corresponding to the expected molecular mass of ϳ50 kDa for N crosslinked to equivalent molar amounts of all the coronavirus RNAs, including a 266-nt leader-containing RNA from the 5Ј end of the BCV genome ( Fig. 5A , lower arrow, lanes 2-7). Two slower migrating species were also strongly crosslinked to the RNAs (Fig. 5A , upper arrow, lanes 2-7). Protein species of the same size also crosslinked to the control pGEM RNA (Fig. 5A , lane 5). However, less protein bound the pGEM RNA than the coronavirus-specific RNA transcripts, consistent with the earlier preliminary filter-binding results, suggesting that N binds coronavirus RNAs better than it binds heterologous RNAs (Cologna and Hogue, 1998) .
Western blotting was used to confirm that the slowermigrating species that crosslinked to the RNAs were indeed his-BCV N. Filter-binding/UV crosslinking reac-tions were assembled with 32 P-labeled Drep RNA and his-tagged BCV N protein. After SDS-PAGE, gels were blotted to nitrocellulose and analyzed by Western blotting using N-specific antibodies, followed by autoradiography ( Fig. 5B , right and left panels, respectively). The slower-migrating ϳ50-kDa crosslinked species and the slowest-migrating higher-molecular-weight species (Fig.  5B , left panel, lane 3, arrows) were identified as N by Western blotting, thus directly confirming that N binds Drep RNA ( Fig. 5B , right panel, lanes 1-3, arrows). The sizes of the slower-migrating forms correspond to those expected for dimer and trimer forms of N.
As a control, bacterially expressed his-tagged dihydrofolate reductase (DHFR) was purified in parallel with his-tagged BCV N and also used in the filter-binding/UV crosslinking assay. This control clearly demonstrated that no proteins in the molecular weight range of N crosslinked to the RNAs (Fig. 5A, lanes 8-14) . However, the results also indicated that a bacterial contaminant with an apparent molecular weight of ϳ15 kDa crosslinked to some of the RNAs (Fig. 5 , lower band in lanes 3, 4, 6, 10, and 13). The contaminant was present in the purified preparation of both his-BCV N and the DHFR control protein, even though both appeared to be more than 90% pure (data not shown). The heavily labeled band that migrated above the bacterial contaminant in lanes 3 and 10 of Fig. 5 is an RNase-resistant structure that was consistently observed with the Drep probe.
Attempts to obtain purified his-tagged N protein preparations that lacked the bacterial contaminant were not successful. In addition to the copurification of the bacterial protein, we also had other concerns about the bacterially expressed protein. The tagged N had been purified under denaturing conditions, and even though the protein had been renatured, this raised concerns that the protein might not be refolding into its native form. Also, the protein was not phosphorylated when expressed in bacteria (data not shown). The role of phosphorylation is not known at this time; however, N is phosphorylated in virus-infected cells and in virions. To circumvent these problems, we chose to use infected cell lysates as the source of N protein for the completion of our study.
Filter-binding reactions were initially set up using Drep and pGEM RNA transcripts and both mock-infected and BCV-infected HCT cell lysates. Filter-binding reactions were assembled in double the normal volume. After incubation half of each reaction was removed and applied directly to nitrocellulose filters. Filters were washed and the amount of bound RNA was determined. The other half of each reaction was immunoprecipitated with N-specific polyclonal antibodies to recover N-RNA complexes. This provided a measurement of the extent to which N was associated with the RNAs that were detected by direct filter binding.
Almost 60% of Drep RNA transcripts were retained on filters after incubation with infected cell lysate, compared with about 15% of the RNA that was incubated with mock-infected lysate (Fig. 6A, Direct) . Roughly 35% of the Drep-infected lysate complexes were immunoprecipitated with N-specific antibodies (Fig. 6A, IP) . Therefore, more than 60% of the Drep RNA that was retained by direct filter binding was recoverable by immunoprecipitation. The amount of pGem RNA retained by direct filter binding with either lysate was similar to the amount of Drep RNA retained by the binding of mock-infected cellular proteins (Fig. 6A , Direct). Only background levels (2-5%) of Drep RNA-protein complexes with mock-infected lysate and pGEM RNA-protein complexes with either lysate were immunoprecipitated with N-specific antibodies (Fig. 6A, IP) . These data demonstrated that proteins in infected cell lysates bound the coronavirus RNA better than they bound noncoronavirus RNAs. The results clearly showed that the viral N protein was stably associated with the majority of these RNA-protein complexes.
We also directly visualized N-binding to Drep RNA. UV crosslinking and Western blotting were performed following incubation of filter-binding reactions. N in BCVinfected cell lysates, but not from mock-infected cells, clearly bound Drep transcripts (Fig. 7A, lanes 2 and 3) .
From our data we cannot absolutely rule out the possibility that other viral proteins also bound Drep RNA and contributed to the increased filter binding with infected cell lysates. From the UV crosslinking results none of the major structural proteins (S, HE, or M) appeared to bind Drep. We expect that some of the viral replicase proteins might also bind regions of the RNA that are involved in RNA replication. However, these proteins are far less abundant than the N protein and most likely would not be detected by UV crosslinking.
To determine whether specific N-binding sites are present within Drep, a series of transcripts were designed to map sequences within the RNA that interact with N. The maximum binding efficiency was measured for each transcript by filter binding (Table 1) . Maximum N-binding efficiency was defined as the percentage of RNA that was retained on the filter, compared to the total amount of labeled RNA added to the reaction. Terminal sequences, including the leader, Pol5Ј, and BCV3ЈNCR were bound much less efficiently than was full-length Drep. The binding efficiencies for these transcripts were similar to the nonviral RNAs pGEM and CAT. Transcripts N, N3Ј, and N3Ј3Ј, all from within the N ORF, were bound at efficiencies ranging from 57 to 73%. These binding efficiencies were comparable to measurements for full-length Drep. Other transcripts, N5Ј and N3Ј SpeI, also from within the N ORF, were bound less efficiently at 22 and 12%, respectively. Only low-level binding was ob- served for all RNAs using mock-infected lysates (data not shown). Taken all together, the data indicated that a high-efficiency N-binding sequence is located within the 3Ј terminal 434 nucleotides of the N ORF.
To directly demonstrate N-binding to the regions that exhibited the highest-efficiency binding, UV crosslinking and Western blotting were performed on filter-binding reactions. N bound the high-efficiency binding transcript N3Ј3Ј that mapped at the 3Ј end of the N ORF (Fig. 7A,  lanes 8 and 9) . However, N was not crosslinked to the Drep fragment N3Ј SpeI that was retained on filters comparably to the noncoronavirus RNAs (Fig. 7A, lanes 6  and 7) , thus directly demonstrating that N accounts for the increased binding observed over the background binding of cellular proteins.
We recently showed that a region of the BCV genome shares homology with the packaging signal of MHV and demonstrated that it is a functional packaging signal (Cologna and Hogue, 2000) . Even though Drep does not contain this region of the genome, we also measured N-binding to this RNA to compare it with the binding data for Drep. About 37% of the BCV pkg transcripts were bound by N, indicating that N interacts with the packaging signal, but interestingly, not as efficiently as with a region of the N ORF. UV crosslinking and Western blotting confirmed that N bound the packaging signal-containing transcript (Fig. 7A, lanes 4 and 5) .
Both MHV-A59 N and BCV N bind MIDI-C at a higher efficiency than does Drep As we mapped the N-binding regions within Drep, we wanted to determine how the high-efficiency binding region within the N ORF compared with efficiency of N-binding to the MHV packaging signal. The MHV DI genome MIDI-C was used for this analysis. At the time these measurements were made, we had not identified the BCV genomic packaging signal. The rationale for our interest in comparing N-binding to MHV and BCV RNAs was discussed earlier. MIDI-C contains a known packaging signal, and MHV and BCV are closely related, but distinct viruses.
Initially we used mock-infected and both BCV-and MHV-A59-infected cell lysates to compare the RNA-binding efficiencies of MIDI-C, Drep, and the MHV packaging signal (Fig. 8) . BCV-and MHV-infected lysates were compared to rule out the possibility that differences in the N proteins from the respective viruses might affect N-RNA interactions ( Figs. 8A and 8B, respectively) . The binding efficiencies for the RNA transcripts were essentially the same for both lysates. The binding efficiencies for all RNAs were much lower when mock-infected lysates from either HCT (Fig. 8B) or 17Cl1 (Fig. 8D ) cells were used. The results demonstrated that N interacts with Drep similar to the interactions of N with the MHV pack- aging signal. The higher level of MIDI-C retention strongly suggested that N might bind other sites in addition to the 69-nt packaging signal within the RNA.
We confirmed that MHV N protein was associated with the majority of the MIDI-C RNA retained by direct filter binding as described above for BCV. Approximately 60% of MIDI-C RNA was retained by direct filter binding in the presence of MHV-infected cell lysates. About 40% of the retained protein-RNA complexes were recovered by immunoprecipitation, thus indicating that at least 67% of the MIDI-C RNA was associated with N ( Fig. 6B) . Only background levels of RNA were recovered by immunoprecipitation when infected lysates were used as the source of protein or when the control pGem RNA was incubated with either lysate (Fig. 6B) .
The MHV packaging signal is not required for highefficiency binding of MIDI-C The difference in binding efficiencies between MIDI-C and its packaging signal led us to extend our mapping analysis of the DI. Maximum binding efficiencies were measured for a series of MIDI-C-deletion transcripts using MHV-infected cell lysates (Table 2) . Binding efficiencies for 3Ј terminal deletions MIDI-C MluI and MIDI-C SpeI were comparable to the binding efficiency for intact MIDI-C RNA. Interestingly, the MIDI-C SpeI transcript lacked the MHV packaging signal. A shorter transcript, MIDI-C EcoRI, from approximately 1.3 kb of the 5Ј end of MIDI-C, exhibited a significantly lower maximum N-binding efficiency when compared to that of full-length MIDI-C. The binding for the ϳ1.3-kb transcript was similar to measurements for MHV pkg, the RNA transcript containing the packaging signal. We also included a transcript of the MHV N ORF in our mapping analysis since we had identified the high-efficiency binding site within the BCV N ORF, as described above. The MHV N transcript had a binding efficiency similar to the MHV pkg RNA. Binding, like that for BCV, mapped to the 3Ј-most region of the MHV N ORF.
To further map the binding region within the polymerase 1a region, a fragment (nts 461-3689) of MIDI-C was subcloned and used to generate four transcripts that encompassed this region. The MHV5Ј SalI transcript bound N as efficiently as MIDI-C RNA. Shorter transcripts, MHV5Ј NspV and MHV5Ј HindIII, exhibited slightly reduced levels of N-binding, compared to those of MIDI-C. Binding was greatly reduced for MHV5Ј AflII 492-nt transcript. This indicated that a high-efficiency binding site maps between the AflII and HindIII sites (nts .
N-binding to full-length MIDI-C, the 5Ј HindIII region from gene 1a, the MHV packaging signal and the 3Ј end of the N ORF was demonstrated directly by UV crosslinking and Western blotting as described earlier (Fig. 7B, lanes 4-9 and 12 and 13 ). No N binding was detected with the N 5Ј3Ј ϳ400-nt transcript from the N ORF in MIDI-C that exhibited only background binding when analyzed by filter binding (Fig. 7B, lanes 10 and  11) .
Collectively, the mapping data for MIDI-C demonstrate that at least three N binding sequences are located in MIDI-C. One maps to a region that includes the packaging signal (nts 3949-4524), a second signal is located in the N ORF (nts 4837-5197), and another within an approximately 1-kb region of the polymerase 1a region (nts 935-1986).
The high-efficiency N-binding region within the BCV N ORF does not function as a packaging signal
The presence of a single high-efficiency binding site within the BCV N ORF was consistent with our initial hypothesis that a packaging signal located within the gene might account for packaging of Drep, and possibly subgenomic RNAs in BCV virions. To test this hypothesis, experiments were performed as we recently described for the identification of a BCV packaging signal (Cologna and Hogue, 2000) . The 3Ј N gene region was subcloned 5Ј to the chloramphenicol acetyltransferase (CAT) gene that contained the hepatitis delta virus ribozyme and T7 terminator at its 3Ј end. The BCV packaging signal appended at the 5Ј end of the CAT-ribozyme-T7 terminator cassette and CAT-ribozyme-T7 terminator construct were used as positive and negative controls, respectively (Cologna and . In addition the CAT-ribozymeterminator cassette was subcloned downstream of fulllength Drep to generate pDrepE-CAT.R.
All plasmid constructs were expressed in BHK cells using the vaccinia recombinant vTF7-3 (Fuerst et al., 1986) , followed by infection with BCV as we described previously (Cologna and Hogue, 2000) . Extracellular BCV virions were collected at 24 h after infection with BCV. Both intracellular and RNase-treated, purified virion RNA were analyzed by Northern blotting with a probe specific for Drep. The results demonstrated that the 3Ј region of the N ORF RNA was not sufficient to target CAT for packaging extracellular BCV virions (Fig. 9, lanes 6 and  16) . Surprisingly, the entire Drep RNA also did not target CAT for packaging ( Fig. 9, lanes 5 and 15) . Implications of these observations are discussed below.
DISCUSSION
This study demonstrates for the first time that N interacts with both genomic and subgenomic RNAs in BCVinfected cells. N-viral RNA complexes were previously shown to be present in cells infected with MHV, a virus that is closely related to BCV . Since the viral leader is common to genomic and subgenomic RNAs, the earlier study suggested that interactions between the leader and N could explain the presence of these complexes in virus-infected cells . N-binding to coronavirus leader RNA supports this idea . Recent biochemical analysis measured a dissociation constant (K d ) of 14 nM for bacterially expressed MHV N-binding to the leader RNA (Nelson et al., 2000) . We also found that N interacts in vitro with both BCV and MHV leader RNAs in the presence of excess nonspecific competitor RNA. Complexes consisting of N and small leader-containing RNAs are present in MHV-infected cells . We have also immunoprecipitated small (Ͼ100 nt) N-leader containing RNA complexes from BCV-infected cells (Cologna and Hogue, unpublished data) .
Taken all together the results from these studies suggest that N-RNA complexes are conserved structures in coronavirus-infected cells. Conservation of such complexes argues in support of the idea that N-RNA interactions play important roles in viral transcription, translation, and/or replication (Nelson et al., 2000) . Our results suggest that interactions between N and the N ORF, a region that is also common to all of the viral RNAs, may contribute, in addition to interactions with the leader, to the formation of the N-RNA complexes that are present in coronavirus-infected cells. Previous studies suggested that N binds nonspecifically to RNA. (Robbins et al., 1986; Masters, 1992) . Our data clearly demonstrate that N binds noncoronavirus and coronavirus RNAs both in vivo and in vitro; however, the protein interacts more efficiently with the latter.
A major goal when we initiated this study was to identify the signal(s) responsible for packaging of the BCV-defective genome Drep. We were particularly interested in this since the defective genome lacks the packaging signal that we subsequently identified within the BCV genome and because BCV packages subgenomic FIG. 9 . Northern blot analysis of chimeric RNA transcripts packaged by 9 and 10, [12] [13] [14] [15] [16] [17] and 19 and 20) were transfected into vTF7-3-infected cells (all lanes). ϩBCV denotes cells that were infected with BCV following transfection (lanes 5-9 and 15-19). Both intracellular RNAs (lanes 1-10) and extracellular virion were analyzed by Northern blotting with a CATspecific probe. Extracellular media were treated with DNase and RNase prior to isolation of virions. Cells were infected only with vTF7-3 and mock-transfected in lanes 1 and 11.
RNAs in addition to genomic RNA (Hofmann et al., 1990; Chang et al., 1994; Cologna and Hogue, 2000) . We mapped one high-efficiency N-binding region in the 3Ј half of the N ORF within Drep RNA. However, a nonviral RNA that contained the N-binding region was not packaged, suggesting that interactions between N and this region of the RNA do not explain why Drep or subgenomics are packaged by BCV. Even though the high-efficiency binding region does not appear to be directly relevant for packaging, interactions between N and this region of the genome may play a role indirectly in the assembly of the helical nucleocapsid. Interestingly we also mapped a high-efficiency N-binding site within the 3Ј half of the MHV N ORF. N presumably binds multiple regions throughout the genomic RNA. High-efficiency N-binding sites, other than the packaging signal, may contribute to the efficiency of packaging, while not being a functional packaging signal.
Surprisingly, when Drep was expressed as part of a chimeric CAT RNA transcript, the RNA was also not packaged by BCV. We cannot rule out the possibility that, if Drep contains a packaging signal, the folding of the chimeric RNA masked it. It is also possible that the defective genome must be replicated subsequent to or concurrent with packaging. Preliminary data in our lab support the idea that replication and packaging may be coupled, and experiments are ongoing to address this.
Different maximum N-binding efficiencies were measured for Drep and MIDI-C, defective genomes for BCV and MHV, respectively. We were able to calculate only rough estimates for K d s since our his-tagged N protein preparations were not absolutely pure. Analysis of our data for N-binding to MIDI-C and Drep RNAs yielded K d s of ϳ21 and ϳ89 nM, respectively. The K d for N binding to noncoronavirus transcripts was ϳ1 mM. The differences in binding activity for MIDI-C and Drep may have important implications for the comparative efficiency with which the two defective genomes are encapsidated and packaged.
Packaging signals have been identified for both MHV and BCV (van der Most et al., 1991; Fosmire et al., 1992; Cologna and Hogue, 2000) . Intuitively one might expect a packaging signal to exhibit the highest N-binding when compared to other parts of the genome. However, this is not the case for MIDI-C, at least under the in vitro conditions used in our study. N bound as efficiently to MIDI-C RNA when the packaging signal was deleted as it did to MIDI-C that contained the packaging signal. Molenkamp and Spaan (1997) initially showed that N binds the MHV packaging signal, but binding affinities were not measured and N-binding sites were not mapped for other regions of MIDI-C. We measured a K d of ϳ100 nM for N-binding to an ϳ600-nt transcript that included the MHV packaging signal. At this time it is not clear what distinguishes other N-binding sites within the genome from N-binding to the packaging signal. Under the in vitro assay conditions used here it appears that binding efficiency might not be the determining factor. However, the context within which the signal is presented within the genome may alter the interactions, even though the packaging signal alone is sufficient to direct an RNA to be packaged in either MHV-or BCVinfected cells (Bos et al., 1997; Woo et al., 1997; Cologna and Hogue, 2000) .
The packaging signal by itself may not determine the efficiency of genomic RNA packaging. Bos and colleagues (1997) inserted an intergenic sequence into MHV MIDI-C to direct the synthesis of a subgenomic RNA containing the MHV packaging signal; the subgenomic was packaged less efficiently than the parental MIDI genomic RNA. This suggests that other factors may be involved in determining the efficiency of packaging. These elements could be a specific sequence(s) or structure(s) that functions as a packaging enhancer by binding N and allowing the RNA to be more efficiently encapsidated and packaged into mature virions. The element(s) within gene 1a that we identified are possibly important in this regard. We are currently testing this possibility. Sequences that enhance packaging have been identified for other viruses. For example, naturally occurring Sindbis virus DI RNAs contain a sequence at the 5Ј end that enhances packaging (Frolova et al., 1997) .
Our data suggest that both monomeric and oligomeric forms of N interact with RNA. These interactions may be important for the assembly of the encapsidated RNA, since it is logical to think that N-N interactions occur in the helical nucleocapsid. Trimeric forms of N associated with both MHV and BCV virions were previously noted (Hogue et al., 1984; Robbins et al., 1986) . In vitro interactions between N monomers were recently reported (Wang and Zhang, 1999) , which is consistent with the ability of N to form multimers associated with RNA. Our data are the first to directly show that oligomers of N bind RNA.
Packaging signals have been identified for a number of viruses, and NC-RNA interactions have been studied for some of these. The Sindbis capsid protein specifically binds with high affinity to a 132-nt region within the viral RNA genome that is a functional packaging signal (Weiss et al., 1994) . The NC protein of human immunodeficiency virus type 1 (HIV-1) binds specifically to several stem loops near the 5Ј end of the genome that constitute a packaging signal. The NC has an apparent K d of about 200 nM for the individual stem loops or 50 nM for the group of stem loops (Clever et al., 2000) .
Interactions between nucleocapsid proteins and RNA for other viruses with helical nucleocapsids have been studied; however, extensive mapping as we describe here has not been done. Influenza virus nucleoprotein NP appears to bind the viral RNA backbone without apparent sequence specificity (Yamanaka et al., 1990; Baudin et al., 1994) . Binding affinity for segment 8 viral RNA (vRNA), conserved 5Ј and 3Ј ends of the vRNAs, and degenerate sequences were all bound at similar affinities with K d s that ranged from 20 to 38 nm. The affinity of vesicular stomatitis virus (VSV) N protein for leader RNA that contains the VSV encapsidation signal is ϳ10 times higher than that for nonspecific sequences (Blumberg et al., 1983) . The results presented here indicate that coronavirus N, like influenza virus NP, does not exhibit absolute specificity for only coronavirus RNAs. However, the protein does appear to preferentially bind coronavirus RNAs. Furthermore, N binds certain regions of the viral RNAs better than others. Binding specificity for encapsidation and packaging in the context of virus-infected cells may be influenced by interactions with the membrane (M) protein or possibly other viral proteins. Compartmentalization of replication complexes in membranous structures may also provide an environment that eliminates the necessity for absolute N-binding specificity.
MATERIALS AND METHODS
Viruses and cell lines
The human adenocarcinoma ileocecal cell line HCT-8 was maintained in Dulbecco's modified Eagle's medium (DMEM). Baby hamster kidney (BHK-21) cells were grown in Glasgow minimal essential medium (GMEM). Both cell lines were obtained from ATCC (Rockville, MD). Mouse 17 clone 1 (17Cl1) cells were propagated in DMEM. All media were supplemented with 10% fetal bovine serum (FBS). Plaque-purified bovine enteric coronavirus (BCV) Mebus strain virus stock was grown and titered on HCT-8 cells as previously described (Nguyen and Hogue, 1997) . The MHV-A59 virus strain was grown on 17Cl1 cells and titered on 17Cl1 and DBT cells. The vTF7-3 recombinant vaccinia virus expressing T7 RNA polymerase (Fuerst et al., 1986) virus stock was grown on HeLa cells and titered on CV-1 and BS-C-1 cells.
Plasmids
Coronavirus-defective genomes, pDrep (Chang et al., 1994) , and pMIDI-C (van der Most et al., 1991) were obtained from David Brian (University of Tennessee-Knoxville) and Willy Spaan (Leiden University, The Netherlands), respectively. Convenient restriction sites, PCR amplification, and standard methods for DNA manipulation were used to generate fragments of the defective genomes (Fig. 1, Tables 1 and 2) . All fragments were subcloned into pGEM-3Zf(ϩ) (Promega, Madison, WI). All PCR products were confirmed by sequencing.
All N fragments were generated from plasmid pB-CVN4.1. Plasmid pBCVN4.1 contains the entire N gene derived from the original MA7 cDNA genomic clone (Lapps et al., 1987) . The clone contains 8 nts 5Ј to the start codon and 24 nts following the stop codon. Plasmid pPol was created by PCR amplification of nucleotides 98 to 472 from the polymerase region of pDrep. BamHI and EcoRI sites were included in the PCR product at the 5Ј and 3Ј ends of the coding sequence, respectively. Plasmid pBCVN5Ј was created by subcloning the EcoRI/BglII fragment from pBCVN4.1 into EcoRI/BamHI restricted vector. The BglII/HindIII fragment of pBCVN4.1 was subcloned into BamHI/HindIII cut vector to construct plasmid pBCVN3Ј. Plasmid pBCVN3Ј3Ј was generated by subcloning the SpeI/HindIII fragment of pBCVN3Ј into XbaI/HindIII cut vector. Plasmid pBCVpkg was previously described (Cologna and Hogue, 2000) . The 5Ј end of the BCV gene 1a was subcloned from Drep by PCR amplification. Construction of pBCV3ЈNCR was previously described (Spagnolo and Hogue, 2000) . Plasmid pBCVN4 contains the entire N gene as described above for pB-CVN4.1 that was modified to contain a hepatitis delta ribozyme and T7 terminator. This was accomplished by subcloning a fragment that contains both elements from plasmid v2.0 (Pattnaik et al., 1992) at the 3Ј end of the N ORF.
Plasmid DrepE-CAT.R was generated by introduction of an EcoRI site at the 5Ј end of Drep and subcloning of a cassette that contained the CAT gene, the hepatitis delta virus ribozyme, and the T7 terminator at the 3Ј end. The other chimeric constructs (BN3Ј-CAT.R, Bpkg-CAT.R, and pGEM-CAT.R) and the CAT cassette were all previously described (Cologna and Hogue, 2000) .
Plasmid pMHVpkg was constructed by PCR amplification of a fragment encompassing nucleotides 3941 to 4529 from pMIDI-C. The PCR strategy introduced an EcoRI site at the 5Ј end of the coding sequence and a BamHI site at the 3Ј end for subcloning purposes. Plasmid pMHVN1 that includes the entire MHV A59 N gene, plus 6 nt 5Ј to the start codon and 16 nt from the 3Ј noncoding region sequences, was PCR-amplified from plasmid pA50 (Masters, 1992) . KpnI and XbaI sites were introduced during amplification at the 5Ј and 3Ј ends of the MHV N coding sequence, respectively. Plasmid pMHV N5Ј was generated by subcloning the 5Ј EcoRI/ NheI fragment from pMHVN and subcloning into EcoRI/ XbaI cut vector. The internal NheI/EcoRI 405 nt fragment from pMHVN was subcloned into EcoRI/XbaI cut vector to create pMHV N⌬5Ј3Ј. Plasmid pMHVN was restricted with EcoRI and the 3.5-kb fragment, which included all of the vector plus 382 nt from the 3Ј end of the N gene, was isolated and religated to make pMHV N3Ј.
Plasmid pNAR1 was generated by subcloning the SmaI/HindIII fragment from v2.0 (Pattnaik et al., 1992) into SmaI/HindIII restricted pNA (Brown et al., 1988) .
Preparation of RNA transcripts
Convenient restriction sites were used to linearize DNAs for in vitro transcription of both unlabeled and [␣ 32 P]CTP-labeled transcripts that were used for filter binding. Transcripts contained 0-38 nt and 0-30 nt at the 5Ј and 3Ј termini, respectively. These exogenous nucleotides were encoded by restriction sites retained from the multiple cloning region of pGEM-3Zf(ϩ) during subcloning. Vector pGEM-3Zf(ϩ) (Promega) that had been cut with ScaI was used to generate runoff of an ϳ1.8-kb transcript as a noncoronavirus control. All positive-sense transcripts, with the exception of BCV pPol and pM-HVN⌬5Ј3Ј that were transcribed from the SP6 promoter, were generated from the T7 promoter. Unlabeled RNAs were transcribed using either Promega or Megascript (Ambion, Austin, TX) reagents according to the manufacturer's protocols. Unlabeled RNAs were monitored on nondenaturing agarose gels stained with ethidium bromide and quantitated by standard absorbance readings at A 260 . DNA templates were removed by digestion with DNase following transcription. Free nucleotides were removed from labeled transcripts using micro Bio-Spin columns (Bio-Rad, Richmond, CA), which has been washed extensively with RNase-free water. RNAs were monitored on nondenaturing agarose gels stained with ethidium bromide. RNAs were quantified and specific activity was calculated using standard protocols.
Capped Drep and MIDI-C RNAs for defective genome replication and packaging studies were generated using T7 MEGAscript kit (Ambion) following the manufacturer's protocol. RNAs were precipitated following DNase treatment and quantified by absorbance at 260 nm; integrity was monitored by electrophoresis on agarose gels and ethidium bromide staining.
Generation of N-specific polyclonal antibodies
A histidine-tagged BCV N fusion protein was expressed and purified from bacteria as previously described (Cologna and Hogue, 1998) . Six histidine residues replaced the first 17 amino acids at the aminoterminus of the BCV N protein. Two female New Zealand White rabbits were inoculated with the purified histagged N protein using standard protocols (Harlow, 1988) . Antibodies were purified by selection over a protein A column (Bio-Rad) as recommended by the manufacturer. Western blotting and immunoprecipitations determined the specificity of the antibodies.
Detection of RNAs associated with N during a BCV infection by agarose gel electrophoresis
Subconfluent monolayers of HCT cells were infected with BCV at a multiplicity of infection (m.o.i.) of 10. After infection cells were incubated in DMEM containing 2% FBS. At 4 h postinfection (p.i.), cells were labeled with [ 32 P]orthophosphate (200 Ci/ml) for 4 h in phosphatefree DMEM containing 5% FBS that had been dialyzed. One dish of mock-and BCV-infected cells was labeled in the presence of 2 g/ml actinomycin D to specifically label only viral RNAs. Total cytoplasmic RNA was iso-lated from cells at 8 h p.i. with TRIzol (Life Technologies, Gaithersburg, MD). To isolate N-associated RNAs, cells were washed with cold PBS and lysed in immunoprecipitation (IP) lysis buffer (10 mM Tris-HCl [pH 7.4], 100 mM NaCl, 20 mM EDTA, 5 mM MgCl 2 , 0.5% Triton X-100, 0.5% sodium deoxycholate [DOC], 1 mM PMSF, and 10 mM iodoacetamide). Nuclei and cell debris were removed by centrifugation at 4°C for 10 min at 13,000 g. Lysates were immunoprecipitated with either preimmune serum, purified 1383 anti-N rabbit polyclonal antibodies, or a mix of monoclonal anti-BCV S ascites antibodies (HB10-4, JB5-6, and HF8-8) (Deregt and Babiuk, 1987) . Protein A-Sepharose-bound immune complexes were washed three times in IP lysis buffer supplemented with 0.1% SDS. Protein-RNA complexes were eluted in 50 l of elution buffer (10 mM Tris-HCl [pH 7.4], 50 mM NaCl, 1 mM EDTA, 200 g/ml yeast tRNA, and 1.0% SDS). RNAs were extracted with TRIzol (Life Technologies), washed with 70% ethanol, and air-dried. Standard conditions for denaturing and electrophoreses on 1% agarose gels containing 2.2 M formaldehyde were followed. The gels were washed extensively with RNase-free water, dried, and autoradiographed.
Isolation of N-RNA complexes formed during vaccinia expression and Northern blot analysis
Subconfluent BHK-21 cells were infected with vTF7-3 (Fuerst et al., 1986 ) at a m.o.i. ϭ 10 for 1 h in GMEM and transfected essentially as previously described (Nguyen and Hogue, 1997) . Following infection, cells were transfected with a total of 15 g of pNA.R1 or pBCVN4.1 DNA using 15 l of Lipofectin (Life Technologies). Cells were harvested 16 h p.i. in IP lysis buffer as described above. The lysates were divided into three aliquots. One aliquot was extracted for total RNA and the other two aliquots were immunoprecipitated with either purified 1383 anti-N rabbit antibodies or anti-NA peptide polyclonal serum (Hogue and Nayak, 1992) . Total RNA samples were treated with RQ1-RNase-free DNase. N-RNA and NA-RNA complexes were immunoprecipitated as described above. RNAs were denatured, electrophoresed on a 1% agarose gel in the presence 2.2 M formaldehyde, transferred to NitroBind membrane (Amersham Pharmacia Biotech, Piscataway, NJ) by vacuum transfer, and probed with either a BCV N gene-specific or an influenza NA gene-specific riboprobe uniformly labeled with [␣-32 P]CTP.
In-solution binding assay
The in-solution binding assay was carried out essentially as described previously (Geigenmuller-Gnirke et al., 1993) . In vitro transcribed, nonlabeled RNAs were incubated with in vitro translated [ 35 S]methionine-labeled N protein in a binding buffer that consisted of 10 mM Tris-HCl (pH 7.4), 100 mM NaCl, 1 mM EDTA, 1 unit RNasin, and 5 g of BHK total cytoplasmic RNA. Total reaction volume was 10 l. The amount of translated N included in each reaction varied from 0.2 to 5 l and was determined by the extent of incorporation of [ 35 S]methionine during translation. Reactions were incubated for 20 min at room temperature and 2 l of dye (20% Ficoll, 0.05% bromophenol blue in 0.25ϫ TBE) was added to each reaction before loading on a 1% nondenaturing agarose gel in 0.25ϫ TBE. Gels were electrophoresed at 30 mA for 4 h, soaked in methanol, dried, and autoradiographed.
Preparation of cell lysates
HCT cells were infected with BCV at a m.o.i. of 5 and harvested at 16 h after infection. MHV-A59-infected 17Cl1 cells were harvested 12 h p.i. Mock-infected cells were maintained and prepared in parallel. Cells were harvested by washing twice with ice-cold PBS and washing briefly with 1ϫ hypotonic buffer containing 10 mM Tris-HCl (pH 7.4), 10 mM NaCl, 1 mM PMSF, 10 mM iodoacetamide, and 1ϫ proteinase-inhibitor cocktail minus EDTA (Boehringer Mannheim, Indianapolis, IN). Cells were scraped into 0.5ϫ hypotonic buffer and incubated on ice for 10 min before Dounce homogenization. Aliquots of the lysates were stored at Ϫ80°C. Protein concentrations were determined for each lysate using the BCA Protein Assay (Pierce, Rockford, IL). Cytoplasmic lysates were stable for about 1 month.
Filter-binding assay
Filter-binding reactions were carried out in a volume of 20 l. Reaction buffer consisted of 10 mM Tris-HCl (pH 7.4), 1 mM DTT, 1 mM EDTA, 250 mM NaCl, 1 unit RNasin, 5.0 g BHK total cytoplasmic RNA, and 10 g heparin. Cytoplasmic lysates or purified proteins (0.5-10 g) were incubated with 0.1 nM of labeled RNA for 20 min at room temperature. Reaction mixtures were filtered through prewetted 0.45-m-pore-size nitrocellulose filters, washed twice with ice-cold wash buffer (10 mM Tris-HCl [pH 7.4], 100 mM NaCl, and 1 mM EDTA) and air-dried. Only RNA complexed with protein was retained on the filters and was detected by Cerenkov counting. The total amount of radioactivity added to each reaction was determined by spotting 0.1 nM of labeled RNA probe onto nitrocellulose filters and Cerenkov counting. The percentage of RNA retained on filters was calculated using the following formula: %RNA ϭ (cpm retained on filter per reaction/total cpm added to the reaction) ϫ 100.
UV crosslinking/Western blotting
Filter-binding reactions were assembled as described above. After incubation reactions were placed on ice and UV-irradiated at 254 nm (UV Stratalinker; Stratagene, La Jolla, CA) at a distance of 10.5 cm for 30 min. After crosslinking, 1 g RNase A and 10 units RNase T 1 were added to each reaction. Reactions were incubated for 15 min at 37°C. SDS-PAGE sample buffer was added to the reactions. Samples were heated at 95°C before being resolved by SDS-PAGE. Following electrophoresis gels were electroblotted to nitrocellulose membranes. Western blots were probed with rabbit anti-N antibodies, followed by goat anti-rabbit secondary IgG conjugated to alkaline phosphatase.
N-RNA complex immunoprecipitation
For immunoprecipitation of N-RNA complexes, filterbinding reactions were assembled as described above. After incubation half of each reaction was analyzed directly for retention of RNA on filters. The other half of each reaction was incubated with purified N-specific antibodies (rabbit 1383) for 30 min on ice, followed by incubation with protein A-Sepharose for 1 h. Immunoprecipitates were washed three times with filter-binding wash buffer. N-RNA complexes bound to protein A-Sepharose were analyzed by Cerenkov counting. The percentage of RNA immunoprecipitated was calculated using the formula: %RNA IP ϭ (cpm bound to protein A-Sepharose/half of the cpm added to binding reaction) ϫ 100.
